SlideShare uma empresa Scribd logo
1 de 22
Baixar para ler offline
Cancer and geneticCancer and genetic
influencesinfluences
1. overview & oncogenes1. overview & oncogenes
Lec 24Lec 24
What is cancer?What is cancer?
A name used to describe a form ofA name used to describe a form of neoplasianeoplasia
 Uncontrolled cell proliferation leading to a mass or tumorUncontrolled cell proliferation leading to a mass or tumor
(neoplasm)(neoplasm)
 Occurs due to imbalance between cellular proliferation andOccurs due to imbalance between cellular proliferation and
cellular deathcellular death
Normal growthNormal growth NeoplasmNeoplasm
Mutations in genesMutations in genes
controllingcontrolling
-prolif or cell cycle.-prolif or cell cycle.
-cytoskeletal-cytoskeletal
inv’ed with contactinv’ed with contact
inhibitioninhibition
-programmed cell-programmed cell
deathdeath
-detecting and-detecting and
repairing DNArepairing DNA
damagedamage
What is cancer?What is cancer?
In addition, the neoplasm must alsoIn addition, the neoplasm must also be malignantbe malignant
NOTE: Tumors that do not invade or spread are not cancerous, butNOTE: Tumors that do not invade or spread are not cancerous, but
referred to asreferred to as benignbenign
growth no longergrowth no longer
controlled and can nowcontrolled and can now
invade neighboringinvade neighboring
tissues and/or spread totissues and/or spread to
more distant sitesmore distant sites
(metastasis)(metastasis)
Major types of cancerMajor types of cancer
CarcinomaCarcinoma
 Derived from epithelial cells, which line surface of skin andDerived from epithelial cells, which line surface of skin and
organs, digestive tract, airways and mammary ductsorgans, digestive tract, airways and mammary ducts
 Most common cancer type (89-90% of all reported cases)Most common cancer type (89-90% of all reported cases)
SarcomaSarcoma
 Derived from mesenchymal tissue – muscle, bone, cartilage, fat,Derived from mesenchymal tissue – muscle, bone, cartilage, fat,
connective tissuesconnective tissues
HematopoieticHematopoietic
 Leukemia – derived from white blood cells or their precursorsLeukemia – derived from white blood cells or their precursors
 Lymphoma – involves cells of the lymphatic systemLymphoma – involves cells of the lymphatic system
 Myelomas – involves white blood cells responsible for theMyelomas – involves white blood cells responsible for the
production of antibodies (B lymphocytes or B-cells)production of antibodies (B lymphocytes or B-cells)
Cancer prefixesCancer prefixes
Examples:Examples:
Osteosarcoma – cancerOsteosarcoma – cancer
arising in bonearising in bone
Hepatocarcinoma –Hepatocarcinoma –
cancer arising in the livercancer arising in the liver
Stages of tumor progressionStages of tumor progression
more growth – abnormalmore growth – abnormal
cellular appearance; maycellular appearance; may
become disorganizedbecome disorganized
uncontrolled cell
division leading to
an excess of cells
cells become primitive incells become primitive in
capability – invasivecapability – invasive
potential existspotential exists
ability to invadeability to invade
&/or metastasize&/or metastasize
Characteristics of cancer cellsCharacteristics of cancer cells
Cytoskeletal changesCytoskeletal changes
Cell adhesion altered – cells able to moveCell adhesion altered – cells able to move
Changes in structure of nucleusChanges in structure of nucleus
Secretion of enzymes that enable them to invadeSecretion of enzymes that enable them to invade
neighboring tissuesneighboring tissues
Unlimited number of cell divisionsUnlimited number of cell divisions
Growth in the absence of “go” signalsGrowth in the absence of “go” signals
Avoidance of cell deathAvoidance of cell death
Tumors stimulate the growth of blood vesselsTumors stimulate the growth of blood vessels
(angiogenesis)(angiogenesis)
Cancer in familiesCancer in families
Many forms have higher incidence in relatives thanMany forms have higher incidence in relatives than
in general populationin general population
Nearly 50 mendelian disorders where risk ofNearly 50 mendelian disorders where risk of
cancer is very high among relativescancer is very high among relatives
For other cancers, the increased incidence is 2-3For other cancers, the increased incidence is 2-3
fold higher for 1fold higher for 1
oo
relatives – complex disorderrelatives – complex disorder
Cancer as a genetic diseaseCancer as a genetic disease
whether sporadic or familial, cancer is fundamentally duewhether sporadic or familial, cancer is fundamentally due
to mutation in various genes controlling cell growth or cellto mutation in various genes controlling cell growth or cell
deathdeath
once initiated, the cancer evolves by accumulatingonce initiated, the cancer evolves by accumulating
additional mutations in other genesadditional mutations in other genes
leads to an ever-worsening cascade of mutationsleads to an ever-worsening cascade of mutations
Original clone of neoplastic cells can evolve intoOriginal clone of neoplastic cells can evolve into
numerous sublineages with different but overlappingnumerous sublineages with different but overlapping
mutationsmutations
Tumor suppressor geneTumor suppressor gene ProtooncogeneProtooncogene
Classifying the genes involvedClassifying the genes involved
in cancerin cancer
OncogenesOncogenes –– mutant forms of genes (proto-mutant forms of genes (proto-
oncogenes) that positively regulate cell proliferationoncogenes) that positively regulate cell proliferation
and cell survivaland cell survival -usu dominant, gain-of-fn mutations-usu dominant, gain-of-fn mutations
Tumor suppressorsTumor suppressors – genes which function to block– genes which function to block
tumor development by negatively regulating cellulartumor development by negatively regulating cellular
growth-growth-usu need loss of both copiesusu need loss of both copies
Cellular maintenance genesCellular maintenance genes – responsible for the– responsible for the
detection and repair of genetic damage in cellsdetection and repair of genetic damage in cells
OncogenesOncogenes
in altered (mutated) form, gene expression leads toin altered (mutated) form, gene expression leads to
abnormal stimulation of cell division and proliferationabnormal stimulation of cell division and proliferation
have a dominant effect at the cellular level – a singlehave a dominant effect at the cellular level – a single
mutant allele is enough to change cellular phenotypemutant allele is enough to change cellular phenotype
from normal to malignant (gain of function)from normal to malignant (gain of function)
Mutations: gene, regulatory region, copy #Mutations: gene, regulatory region, copy #
normalnormal mutantmutant
OncogenesOncogenes
in its normal form, thein its normal form, the
gene is called agene is called a
proto-oncogeneproto-oncogene
Most proto-oncogenesMost proto-oncogenes
are components ofare components of
signal transductionsignal transduction
pathways:pathways:
translate extracellulartranslate extracellular
signals into changes insignals into changes in
gene expressiongene expression
Increase blood supplyIncrease blood supply
to the tumor or inhibitto the tumor or inhibit
apoptosisapoptosis
RET, METRET, MET
Receptor tyrosine kinasesReceptor tyrosine kinases
-transduce an extracellular-transduce an extracellular
signal inwardsignal inward
-bind a ligand, conformational-bind a ligand, conformational
change that results in kinasechange that results in kinase
activity, leading to phosphor-activity, leading to phosphor-
lation of cellular proteinslation of cellular proteins
-pt mut’s cause receptors to-pt mut’s cause receptors to
be constitutively activebe constitutively active
RET mut-multiple endocrineRET mut-multiple endocrine
neoplasianeoplasia
MET mut-hereditary papillaryMET mut-hereditary papillary
renal carcinomarenal carcinoma
Ras, AblRas, Abl
MycMyc
RAS family of proto-oncogenesRAS family of proto-oncogenes
One of the first activated oncogenes discovered by theOne of the first activated oncogenes discovered by the
DNA transformation assayDNA transformation assay
Encodes a small guanosine triphosphate (GTP) –Encodes a small guanosine triphosphate (GTP) –
binding protein (G-protein)binding protein (G-protein)
3 members of this family; H-RAS, K-RAS, N-RAS3 members of this family; H-RAS, K-RAS, N-RAS
Serves as an “on/off” switch to activate or inhibitServes as an “on/off” switch to activate or inhibit
downstream molecules when bound to GTPdownstream molecules when bound to GTP
The protein’s effect is ended by self-directed cleavageThe protein’s effect is ended by self-directed cleavage
of GTPof GTP
RAS family of proto-oncogenesRAS family of proto-oncogenes
Ras associates with the plasma membraneRas associates with the plasma membrane
Ras relays signals from the cell surface receptors toRas relays signals from the cell surface receptors to
the nucleus, functioning as athe nucleus, functioning as a switchswitch
 ‘‘Active’ when GTP is boundActive’ when GTP is bound
 ‘‘Inactive when the hydrolyzed GDP is boundInactive when the hydrolyzed GDP is bound
RAS mutation in humanRAS mutation in human
cancerscancers
H-RAS mutated in 10% of all bladder cancer
K-RAS mutations in about 50% of
colorectal cancers, 70-90% of pancreatic
cancers and 30% of lung adenocarcinomas as
well as in ovarian, breast skin liver and kidney
N-RAS mutations have been detected in 20-
30% of acute nonlymphocytic leukemias
RAS oncogene activation byRAS oncogene activation by
nucleotide substitutionnucleotide substitution
Conversion to oncogene usually due to a pointConversion to oncogene usually due to a point
mutation in the gene where:mutation in the gene where:
 the ras protein is able to signal continuously, even inthe ras protein is able to signal continuously, even in
absenceabsence of GTPof GTP

the ras protein isthe ras protein is unable to hydrolyze GTPunable to hydrolyze GTP toto
turn “off” the signalturn “off” the signal
Leads to the continuous activation of multipleLeads to the continuous activation of multiple
downstream signaling pathways inducing celldownstream signaling pathways inducing cell
proliferationproliferation
Mutations in the 3 RAS genes are found in 10-15% ofMutations in the 3 RAS genes are found in 10-15% of
all human cancersall human cancers
Oncogenes are also activatedOncogenes are also activated
by chromosome translocationsby chromosome translocations
Breakpoint can occur withinBreakpoint can occur within
introns of two genes: chimericintrons of two genes: chimeric
protein with novel properties –protein with novel properties –
Chronic MyelogenousChronic Myelogenous
Leukemia-Leukemia-UncontrolledUncontrolled
proliferation of white bloodproliferation of white blood
cellscells
Arises in a bone marrow stemArises in a bone marrow stem
cell that is a precursor to thecell that is a precursor to the
granulocytes andgranulocytes and
megakaryocytesmegakaryocytes
These cells contain a chr 9;22These cells contain a chr 9;22
translocation – “Philadelphiatranslocation – “Philadelphia
Chromosome”Chromosome”
Protooncogene ABL, a tyrosine
kinase, is moved from its normal
position on 9 to 22.
Result: increased activity
Chronic MyelogenousChronic Myelogenous
Leukemia (CML)Leukemia (CML) Proto-oncogene ABLProto-oncogene ABL
(tyrosine kinase) moves(tyrosine kinase) moves
from 9q to thefrom 9q to the
“breakpoint cluster region“breakpoint cluster region
(BCR) on 22q(BCR) on 22q
Chimeric protein hasChimeric protein has
increased tyrosine kinaseincreased tyrosine kinase
activity but alteredactivity but altered
structure and functionstructure and function
Requires secondaryRequires secondary
mutation to move intomutation to move into
crisis phasecrisis phase
Effective drug therapyEffective drug therapy
developed to target noveldeveloped to target novel
proteinprotein
Oncogenes are also activatedOncogenes are also activated
by chromosome translocationsby chromosome translocations
Breakpoint can occur withinBreakpoint can occur within
introns of two genes: chimericintrons of two genes: chimeric
protein with novel properties –protein with novel properties –
Chronic MyelogenousChronic Myelogenous
LeukemiaLeukemia
Alternately, translocation mayAlternately, translocation may
place proto-oncogeneplace proto-oncogene
downstream of a strongdownstream of a strong
constitutive promoter fromconstitutive promoter from
another gene – proto-another gene – proto-
oncogene is now expressed atoncogene is now expressed at
inappropriate time/place –inappropriate time/place –
Burkitt LymphomaBurkitt Lymphoma
Burkitt LymphomaBurkitt Lymphoma
B-cell tumorB-cell tumor
MYC proto-oncogeneMYC proto-oncogene
(transcription factor)(transcription factor)
translocated from 8q24translocated from 8q24
to 14q32, distal of the Igto 14q32, distal of the Ig
heavy chain locusheavy chain locus
Ig enhancers orIg enhancers or
activating sequences actactivating sequences act
on MYC – allowing foron MYC – allowing for
unregulated expressionunregulated expression
and uncontrolled celland uncontrolled cell
growthgrowth
http://tooldoc.wncc.edu/Infections/lymphoma.JPG
• Solid tumor of B-lymphocytes
• Predominantly affecting young children
in Africa,
• one of the fastest growing malignancies
in humans.
• manifested most often as a large jaw
lesion expands rapidly over a period of
a few weeks to invade the orbit.
• Visceral involvement, usually an
abdominal mass
• Treatment of the jaw and eye areas is by
radiotherapy,while visceral involvement
requires systemic chemotherapy.
In all cases, translocation of MYC is the cause

Mais conteúdo relacionado

Mais procurados

Cancer Genes And Growth Factors
Cancer Genes And Growth FactorsCancer Genes And Growth Factors
Cancer Genes And Growth Factorsalaa essa
 
Epigenetic in Cancer
Epigenetic in CancerEpigenetic in Cancer
Epigenetic in CancerAbeer Ibrahim
 
Tumour suppressor genes
Tumour suppressor genes Tumour suppressor genes
Tumour suppressor genes Dhanya K C
 
Oncogene and tumor suppressor gene
Oncogene and tumor suppressor geneOncogene and tumor suppressor gene
Oncogene and tumor suppressor geneAJEESH BL
 
Proto oncogene to onco gene cell signaling
Proto oncogene to onco gene cell signalingProto oncogene to onco gene cell signaling
Proto oncogene to onco gene cell signalingRiniJoseph8
 
Role of apoptosis in cancer progression
Role of apoptosis in cancer progressionRole of apoptosis in cancer progression
Role of apoptosis in cancer progressionmonicka17lohan
 
Cancer biochemistry
Cancer biochemistry  Cancer biochemistry
Cancer biochemistry rohini sane
 
Molecular Genetics of Cancer
Molecular Genetics of CancerMolecular Genetics of Cancer
Molecular Genetics of CancerNeha Vats
 
Tumor suppressor genes
Tumor suppressor genesTumor suppressor genes
Tumor suppressor genesfatmafars
 
Oncogenes and tumour suppressor genes
Oncogenes and tumour suppressor genes Oncogenes and tumour suppressor genes
Oncogenes and tumour suppressor genes rakhavem
 
Epigenetics: Introduction and Definition and the mechanism
Epigenetics: Introduction and Definition and the mechanismEpigenetics: Introduction and Definition and the mechanism
Epigenetics: Introduction and Definition and the mechanismMohit Adhikary
 

Mais procurados (20)

Cancer Genes And Growth Factors
Cancer Genes And Growth FactorsCancer Genes And Growth Factors
Cancer Genes And Growth Factors
 
Oncogene
OncogeneOncogene
Oncogene
 
Epigenetic in Cancer
Epigenetic in CancerEpigenetic in Cancer
Epigenetic in Cancer
 
ONCOGENES
ONCOGENESONCOGENES
ONCOGENES
 
Tumour suppressor genes
Tumour suppressor genes Tumour suppressor genes
Tumour suppressor genes
 
Oncogenes
Oncogenes Oncogenes
Oncogenes
 
Epigenetics
Epigenetics Epigenetics
Epigenetics
 
Epigenetic
EpigeneticEpigenetic
Epigenetic
 
P53
P53P53
P53
 
Oncogene and tumor suppressor gene
Oncogene and tumor suppressor geneOncogene and tumor suppressor gene
Oncogene and tumor suppressor gene
 
Proto oncogene to onco gene cell signaling
Proto oncogene to onco gene cell signalingProto oncogene to onco gene cell signaling
Proto oncogene to onco gene cell signaling
 
Role of apoptosis in cancer progression
Role of apoptosis in cancer progressionRole of apoptosis in cancer progression
Role of apoptosis in cancer progression
 
Cancer biochemistry
Cancer biochemistry  Cancer biochemistry
Cancer biochemistry
 
Molecular Genetics of Cancer
Molecular Genetics of CancerMolecular Genetics of Cancer
Molecular Genetics of Cancer
 
Tumor suppressor genes
Tumor suppressor genesTumor suppressor genes
Tumor suppressor genes
 
Oncogenes and tumour suppressor genes
Oncogenes and tumour suppressor genes Oncogenes and tumour suppressor genes
Oncogenes and tumour suppressor genes
 
Microbiology:Oncogenes
Microbiology:Oncogenes Microbiology:Oncogenes
Microbiology:Oncogenes
 
Epigenetics: Introduction and Definition and the mechanism
Epigenetics: Introduction and Definition and the mechanismEpigenetics: Introduction and Definition and the mechanism
Epigenetics: Introduction and Definition and the mechanism
 
Cancer genetics
Cancer geneticsCancer genetics
Cancer genetics
 
Telomerase
TelomeraseTelomerase
Telomerase
 

Destaque (20)

7.Cancer Genetics.Oct.09
7.Cancer Genetics.Oct.097.Cancer Genetics.Oct.09
7.Cancer Genetics.Oct.09
 
Know Cancer statistics in India | Major Types of Cancer Affecting Indians
Know Cancer statistics in India | Major Types of Cancer Affecting Indians Know Cancer statistics in India | Major Types of Cancer Affecting Indians
Know Cancer statistics in India | Major Types of Cancer Affecting Indians
 
Cancer
CancerCancer
Cancer
 
Modeling Myc Inhibition In Vitro [Presentation]
Modeling Myc Inhibition In Vitro [Presentation]Modeling Myc Inhibition In Vitro [Presentation]
Modeling Myc Inhibition In Vitro [Presentation]
 
MYC Project Summary
MYC Project SummaryMYC Project Summary
MYC Project Summary
 
linfoma-de-burkitt
linfoma-de-burkittlinfoma-de-burkitt
linfoma-de-burkitt
 
oncogene as a transcription activator
oncogene as a transcription activatoroncogene as a transcription activator
oncogene as a transcription activator
 
Boc Lecture 4 the hallmarks of cancer km
Boc Lecture 4 the hallmarks of cancer  kmBoc Lecture 4 the hallmarks of cancer  km
Boc Lecture 4 the hallmarks of cancer km
 
Burkitt lymphoma Beyond MYC
Burkitt lymphoma Beyond MYCBurkitt lymphoma Beyond MYC
Burkitt lymphoma Beyond MYC
 
Proto-oncogene
Proto-oncogeneProto-oncogene
Proto-oncogene
 
Neoplasia 1
Neoplasia 1Neoplasia 1
Neoplasia 1
 
Hec ras
Hec rasHec ras
Hec ras
 
Oncogenic viruses
Oncogenic virusesOncogenic viruses
Oncogenic viruses
 
Molecular basis of Cancer
Molecular basis of CancerMolecular basis of Cancer
Molecular basis of Cancer
 
Oncogene
OncogeneOncogene
Oncogene
 
Oncogenes&Cancer
Oncogenes&CancerOncogenes&Cancer
Oncogenes&Cancer
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Oncogenes
OncogenesOncogenes
Oncogenes
 
What is Cancer Presentation
What is Cancer PresentationWhat is Cancer Presentation
What is Cancer Presentation
 
Neoplasia Characteristics and classification of cancer
Neoplasia Characteristics and classification of cancerNeoplasia Characteristics and classification of cancer
Neoplasia Characteristics and classification of cancer
 

Semelhante a Cancer and genetic influences

Cancer and tumor markers
Cancer and tumor markersCancer and tumor markers
Cancer and tumor markersKshema Thakur
 
Neoplasia its Development Mechanisms and Neoplastic diseases
Neoplasia its Development Mechanisms and Neoplastic diseasesNeoplasia its Development Mechanisms and Neoplastic diseases
Neoplasia its Development Mechanisms and Neoplastic diseasesFarazaJaved
 
NORMAL-CELLS-versus-CANCER-CELLS.pptxssss
NORMAL-CELLS-versus-CANCER-CELLS.pptxssssNORMAL-CELLS-versus-CANCER-CELLS.pptxssss
NORMAL-CELLS-versus-CANCER-CELLS.pptxssssRashadHamada
 
Cancer (Concept of oncogenes and tumor suppressor genes with special referenc...
Cancer (Concept of oncogenes and tumor suppressor genes with special referenc...Cancer (Concept of oncogenes and tumor suppressor genes with special referenc...
Cancer (Concept of oncogenes and tumor suppressor genes with special referenc...RubinSahu5
 
Molecular biology of cancer
Molecular biology of cancerMolecular biology of cancer
Molecular biology of cancerNawfal Aldujaily
 
Biochemistry of cancer
Biochemistry of cancer Biochemistry of cancer
Biochemistry of cancer Ashok Katta
 
Molecular mechanism of neoplasia
Molecular mechanism of neoplasiaMolecular mechanism of neoplasia
Molecular mechanism of neoplasiaUtkarsh Sharma
 
Biology And Pathophysiology Of Cancer
Biology And Pathophysiology Of CancerBiology And Pathophysiology Of Cancer
Biology And Pathophysiology Of CancerRHMBONCO
 
Carcinomagenesis Theories .pdf
Carcinomagenesis Theories .pdfCarcinomagenesis Theories .pdf
Carcinomagenesis Theories .pdfMohitChauhan270470
 

Semelhante a Cancer and genetic influences (20)

Cancer genetics
Cancer geneticsCancer genetics
Cancer genetics
 
Cancer and tumor markers
Cancer and tumor markersCancer and tumor markers
Cancer and tumor markers
 
Neoplasia its Development Mechanisms and Neoplastic diseases
Neoplasia its Development Mechanisms and Neoplastic diseasesNeoplasia its Development Mechanisms and Neoplastic diseases
Neoplasia its Development Mechanisms and Neoplastic diseases
 
NORMAL-CELLS-versus-CANCER-CELLS.pptxssss
NORMAL-CELLS-versus-CANCER-CELLS.pptxssssNORMAL-CELLS-versus-CANCER-CELLS.pptxssss
NORMAL-CELLS-versus-CANCER-CELLS.pptxssss
 
ONCOGENE AND TUMOUR SUPPRESSOR GENE
ONCOGENE AND TUMOUR SUPPRESSOR GENEONCOGENE AND TUMOUR SUPPRESSOR GENE
ONCOGENE AND TUMOUR SUPPRESSOR GENE
 
Microbiology:Tumor Suppressor Genes
Microbiology:Tumor Suppressor GenesMicrobiology:Tumor Suppressor Genes
Microbiology:Tumor Suppressor Genes
 
Cancer (Concept of oncogenes and tumor suppressor genes with special referenc...
Cancer (Concept of oncogenes and tumor suppressor genes with special referenc...Cancer (Concept of oncogenes and tumor suppressor genes with special referenc...
Cancer (Concept of oncogenes and tumor suppressor genes with special referenc...
 
Oncovirus
OncovirusOncovirus
Oncovirus
 
Oncogenesis
OncogenesisOncogenesis
Oncogenesis
 
Molecular biology of cancer
Molecular biology of cancerMolecular biology of cancer
Molecular biology of cancer
 
Tumor pathogenesis
Tumor pathogenesisTumor pathogenesis
Tumor pathogenesis
 
Genetics of cancer
Genetics of cancerGenetics of cancer
Genetics of cancer
 
Cancercell
CancercellCancercell
Cancercell
 
CANCER
CANCERCANCER
CANCER
 
Biochemistry of cancer
Biochemistry of cancer Biochemistry of cancer
Biochemistry of cancer
 
Oncogenes
OncogenesOncogenes
Oncogenes
 
Molecular mechanism of neoplasia
Molecular mechanism of neoplasiaMolecular mechanism of neoplasia
Molecular mechanism of neoplasia
 
Biology And Pathophysiology Of Cancer
Biology And Pathophysiology Of CancerBiology And Pathophysiology Of Cancer
Biology And Pathophysiology Of Cancer
 
Carcinogenesis
CarcinogenesisCarcinogenesis
Carcinogenesis
 
Carcinomagenesis Theories .pdf
Carcinomagenesis Theories .pdfCarcinomagenesis Theories .pdf
Carcinomagenesis Theories .pdf
 

Último

BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
AI in Action: Elevating Patient Insights
AI in Action: Elevating Patient InsightsAI in Action: Elevating Patient Insights
AI in Action: Elevating Patient InsightsEmily Kunka, MS, CCRP
 
Transport across cell membrane (passive, active, vesicular)
Transport across cell membrane (passive, active, vesicular)Transport across cell membrane (passive, active, vesicular)
Transport across cell membrane (passive, active, vesicular)MedicoseAcademics
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
Arthroscopic Surgery in Indore : A Minimally Invasive Guide to Joint Health
Arthroscopic Surgery in Indore : A Minimally Invasive Guide to Joint HealthArthroscopic Surgery in Indore : A Minimally Invasive Guide to Joint Health
Arthroscopic Surgery in Indore : A Minimally Invasive Guide to Joint HealthGokuldas Hospital
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
Understanding AIDS:a roadmap to well ess
Understanding AIDS:a roadmap to well essUnderstanding AIDS:a roadmap to well ess
Understanding AIDS:a roadmap to well essAbhishekKumar524514
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 

Último (20)

BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
AI in Action: Elevating Patient Insights
AI in Action: Elevating Patient InsightsAI in Action: Elevating Patient Insights
AI in Action: Elevating Patient Insights
 
Transport across cell membrane (passive, active, vesicular)
Transport across cell membrane (passive, active, vesicular)Transport across cell membrane (passive, active, vesicular)
Transport across cell membrane (passive, active, vesicular)
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
Arthroscopic Surgery in Indore : A Minimally Invasive Guide to Joint Health
Arthroscopic Surgery in Indore : A Minimally Invasive Guide to Joint HealthArthroscopic Surgery in Indore : A Minimally Invasive Guide to Joint Health
Arthroscopic Surgery in Indore : A Minimally Invasive Guide to Joint Health
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
Understanding AIDS:a roadmap to well ess
Understanding AIDS:a roadmap to well essUnderstanding AIDS:a roadmap to well ess
Understanding AIDS:a roadmap to well ess
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 

Cancer and genetic influences

  • 1. Cancer and geneticCancer and genetic influencesinfluences 1. overview & oncogenes1. overview & oncogenes Lec 24Lec 24
  • 2. What is cancer?What is cancer? A name used to describe a form ofA name used to describe a form of neoplasianeoplasia  Uncontrolled cell proliferation leading to a mass or tumorUncontrolled cell proliferation leading to a mass or tumor (neoplasm)(neoplasm)  Occurs due to imbalance between cellular proliferation andOccurs due to imbalance between cellular proliferation and cellular deathcellular death Normal growthNormal growth NeoplasmNeoplasm Mutations in genesMutations in genes controllingcontrolling -prolif or cell cycle.-prolif or cell cycle. -cytoskeletal-cytoskeletal inv’ed with contactinv’ed with contact inhibitioninhibition -programmed cell-programmed cell deathdeath -detecting and-detecting and repairing DNArepairing DNA damagedamage
  • 3. What is cancer?What is cancer? In addition, the neoplasm must alsoIn addition, the neoplasm must also be malignantbe malignant NOTE: Tumors that do not invade or spread are not cancerous, butNOTE: Tumors that do not invade or spread are not cancerous, but referred to asreferred to as benignbenign growth no longergrowth no longer controlled and can nowcontrolled and can now invade neighboringinvade neighboring tissues and/or spread totissues and/or spread to more distant sitesmore distant sites (metastasis)(metastasis)
  • 4. Major types of cancerMajor types of cancer CarcinomaCarcinoma  Derived from epithelial cells, which line surface of skin andDerived from epithelial cells, which line surface of skin and organs, digestive tract, airways and mammary ductsorgans, digestive tract, airways and mammary ducts  Most common cancer type (89-90% of all reported cases)Most common cancer type (89-90% of all reported cases) SarcomaSarcoma  Derived from mesenchymal tissue – muscle, bone, cartilage, fat,Derived from mesenchymal tissue – muscle, bone, cartilage, fat, connective tissuesconnective tissues HematopoieticHematopoietic  Leukemia – derived from white blood cells or their precursorsLeukemia – derived from white blood cells or their precursors  Lymphoma – involves cells of the lymphatic systemLymphoma – involves cells of the lymphatic system  Myelomas – involves white blood cells responsible for theMyelomas – involves white blood cells responsible for the production of antibodies (B lymphocytes or B-cells)production of antibodies (B lymphocytes or B-cells)
  • 5. Cancer prefixesCancer prefixes Examples:Examples: Osteosarcoma – cancerOsteosarcoma – cancer arising in bonearising in bone Hepatocarcinoma –Hepatocarcinoma – cancer arising in the livercancer arising in the liver
  • 6. Stages of tumor progressionStages of tumor progression more growth – abnormalmore growth – abnormal cellular appearance; maycellular appearance; may become disorganizedbecome disorganized uncontrolled cell division leading to an excess of cells cells become primitive incells become primitive in capability – invasivecapability – invasive potential existspotential exists ability to invadeability to invade &/or metastasize&/or metastasize
  • 7. Characteristics of cancer cellsCharacteristics of cancer cells Cytoskeletal changesCytoskeletal changes Cell adhesion altered – cells able to moveCell adhesion altered – cells able to move Changes in structure of nucleusChanges in structure of nucleus Secretion of enzymes that enable them to invadeSecretion of enzymes that enable them to invade neighboring tissuesneighboring tissues Unlimited number of cell divisionsUnlimited number of cell divisions Growth in the absence of “go” signalsGrowth in the absence of “go” signals Avoidance of cell deathAvoidance of cell death Tumors stimulate the growth of blood vesselsTumors stimulate the growth of blood vessels (angiogenesis)(angiogenesis)
  • 8. Cancer in familiesCancer in families Many forms have higher incidence in relatives thanMany forms have higher incidence in relatives than in general populationin general population Nearly 50 mendelian disorders where risk ofNearly 50 mendelian disorders where risk of cancer is very high among relativescancer is very high among relatives For other cancers, the increased incidence is 2-3For other cancers, the increased incidence is 2-3 fold higher for 1fold higher for 1 oo relatives – complex disorderrelatives – complex disorder
  • 9. Cancer as a genetic diseaseCancer as a genetic disease whether sporadic or familial, cancer is fundamentally duewhether sporadic or familial, cancer is fundamentally due to mutation in various genes controlling cell growth or cellto mutation in various genes controlling cell growth or cell deathdeath once initiated, the cancer evolves by accumulatingonce initiated, the cancer evolves by accumulating additional mutations in other genesadditional mutations in other genes leads to an ever-worsening cascade of mutationsleads to an ever-worsening cascade of mutations Original clone of neoplastic cells can evolve intoOriginal clone of neoplastic cells can evolve into numerous sublineages with different but overlappingnumerous sublineages with different but overlapping mutationsmutations Tumor suppressor geneTumor suppressor gene ProtooncogeneProtooncogene
  • 10. Classifying the genes involvedClassifying the genes involved in cancerin cancer OncogenesOncogenes –– mutant forms of genes (proto-mutant forms of genes (proto- oncogenes) that positively regulate cell proliferationoncogenes) that positively regulate cell proliferation and cell survivaland cell survival -usu dominant, gain-of-fn mutations-usu dominant, gain-of-fn mutations Tumor suppressorsTumor suppressors – genes which function to block– genes which function to block tumor development by negatively regulating cellulartumor development by negatively regulating cellular growth-growth-usu need loss of both copiesusu need loss of both copies Cellular maintenance genesCellular maintenance genes – responsible for the– responsible for the detection and repair of genetic damage in cellsdetection and repair of genetic damage in cells
  • 11. OncogenesOncogenes in altered (mutated) form, gene expression leads toin altered (mutated) form, gene expression leads to abnormal stimulation of cell division and proliferationabnormal stimulation of cell division and proliferation have a dominant effect at the cellular level – a singlehave a dominant effect at the cellular level – a single mutant allele is enough to change cellular phenotypemutant allele is enough to change cellular phenotype from normal to malignant (gain of function)from normal to malignant (gain of function) Mutations: gene, regulatory region, copy #Mutations: gene, regulatory region, copy # normalnormal mutantmutant
  • 12. OncogenesOncogenes in its normal form, thein its normal form, the gene is called agene is called a proto-oncogeneproto-oncogene Most proto-oncogenesMost proto-oncogenes are components ofare components of signal transductionsignal transduction pathways:pathways: translate extracellulartranslate extracellular signals into changes insignals into changes in gene expressiongene expression Increase blood supplyIncrease blood supply to the tumor or inhibitto the tumor or inhibit apoptosisapoptosis
  • 13. RET, METRET, MET Receptor tyrosine kinasesReceptor tyrosine kinases -transduce an extracellular-transduce an extracellular signal inwardsignal inward -bind a ligand, conformational-bind a ligand, conformational change that results in kinasechange that results in kinase activity, leading to phosphor-activity, leading to phosphor- lation of cellular proteinslation of cellular proteins -pt mut’s cause receptors to-pt mut’s cause receptors to be constitutively activebe constitutively active RET mut-multiple endocrineRET mut-multiple endocrine neoplasianeoplasia MET mut-hereditary papillaryMET mut-hereditary papillary renal carcinomarenal carcinoma Ras, AblRas, Abl MycMyc
  • 14. RAS family of proto-oncogenesRAS family of proto-oncogenes One of the first activated oncogenes discovered by theOne of the first activated oncogenes discovered by the DNA transformation assayDNA transformation assay Encodes a small guanosine triphosphate (GTP) –Encodes a small guanosine triphosphate (GTP) – binding protein (G-protein)binding protein (G-protein) 3 members of this family; H-RAS, K-RAS, N-RAS3 members of this family; H-RAS, K-RAS, N-RAS Serves as an “on/off” switch to activate or inhibitServes as an “on/off” switch to activate or inhibit downstream molecules when bound to GTPdownstream molecules when bound to GTP The protein’s effect is ended by self-directed cleavageThe protein’s effect is ended by self-directed cleavage of GTPof GTP
  • 15. RAS family of proto-oncogenesRAS family of proto-oncogenes Ras associates with the plasma membraneRas associates with the plasma membrane Ras relays signals from the cell surface receptors toRas relays signals from the cell surface receptors to the nucleus, functioning as athe nucleus, functioning as a switchswitch  ‘‘Active’ when GTP is boundActive’ when GTP is bound  ‘‘Inactive when the hydrolyzed GDP is boundInactive when the hydrolyzed GDP is bound
  • 16. RAS mutation in humanRAS mutation in human cancerscancers H-RAS mutated in 10% of all bladder cancer K-RAS mutations in about 50% of colorectal cancers, 70-90% of pancreatic cancers and 30% of lung adenocarcinomas as well as in ovarian, breast skin liver and kidney N-RAS mutations have been detected in 20- 30% of acute nonlymphocytic leukemias
  • 17. RAS oncogene activation byRAS oncogene activation by nucleotide substitutionnucleotide substitution Conversion to oncogene usually due to a pointConversion to oncogene usually due to a point mutation in the gene where:mutation in the gene where:  the ras protein is able to signal continuously, even inthe ras protein is able to signal continuously, even in absenceabsence of GTPof GTP  the ras protein isthe ras protein is unable to hydrolyze GTPunable to hydrolyze GTP toto turn “off” the signalturn “off” the signal Leads to the continuous activation of multipleLeads to the continuous activation of multiple downstream signaling pathways inducing celldownstream signaling pathways inducing cell proliferationproliferation Mutations in the 3 RAS genes are found in 10-15% ofMutations in the 3 RAS genes are found in 10-15% of all human cancersall human cancers
  • 18. Oncogenes are also activatedOncogenes are also activated by chromosome translocationsby chromosome translocations Breakpoint can occur withinBreakpoint can occur within introns of two genes: chimericintrons of two genes: chimeric protein with novel properties –protein with novel properties – Chronic MyelogenousChronic Myelogenous Leukemia-Leukemia-UncontrolledUncontrolled proliferation of white bloodproliferation of white blood cellscells Arises in a bone marrow stemArises in a bone marrow stem cell that is a precursor to thecell that is a precursor to the granulocytes andgranulocytes and megakaryocytesmegakaryocytes These cells contain a chr 9;22These cells contain a chr 9;22 translocation – “Philadelphiatranslocation – “Philadelphia Chromosome”Chromosome” Protooncogene ABL, a tyrosine kinase, is moved from its normal position on 9 to 22. Result: increased activity
  • 19. Chronic MyelogenousChronic Myelogenous Leukemia (CML)Leukemia (CML) Proto-oncogene ABLProto-oncogene ABL (tyrosine kinase) moves(tyrosine kinase) moves from 9q to thefrom 9q to the “breakpoint cluster region“breakpoint cluster region (BCR) on 22q(BCR) on 22q Chimeric protein hasChimeric protein has increased tyrosine kinaseincreased tyrosine kinase activity but alteredactivity but altered structure and functionstructure and function Requires secondaryRequires secondary mutation to move intomutation to move into crisis phasecrisis phase Effective drug therapyEffective drug therapy developed to target noveldeveloped to target novel proteinprotein
  • 20. Oncogenes are also activatedOncogenes are also activated by chromosome translocationsby chromosome translocations Breakpoint can occur withinBreakpoint can occur within introns of two genes: chimericintrons of two genes: chimeric protein with novel properties –protein with novel properties – Chronic MyelogenousChronic Myelogenous LeukemiaLeukemia Alternately, translocation mayAlternately, translocation may place proto-oncogeneplace proto-oncogene downstream of a strongdownstream of a strong constitutive promoter fromconstitutive promoter from another gene – proto-another gene – proto- oncogene is now expressed atoncogene is now expressed at inappropriate time/place –inappropriate time/place – Burkitt LymphomaBurkitt Lymphoma
  • 21. Burkitt LymphomaBurkitt Lymphoma B-cell tumorB-cell tumor MYC proto-oncogeneMYC proto-oncogene (transcription factor)(transcription factor) translocated from 8q24translocated from 8q24 to 14q32, distal of the Igto 14q32, distal of the Ig heavy chain locusheavy chain locus Ig enhancers orIg enhancers or activating sequences actactivating sequences act on MYC – allowing foron MYC – allowing for unregulated expressionunregulated expression and uncontrolled celland uncontrolled cell growthgrowth
  • 22. http://tooldoc.wncc.edu/Infections/lymphoma.JPG • Solid tumor of B-lymphocytes • Predominantly affecting young children in Africa, • one of the fastest growing malignancies in humans. • manifested most often as a large jaw lesion expands rapidly over a period of a few weeks to invade the orbit. • Visceral involvement, usually an abdominal mass • Treatment of the jaw and eye areas is by radiotherapy,while visceral involvement requires systemic chemotherapy. In all cases, translocation of MYC is the cause

Notas do Editor

  1. Cancer is abnormal cellular
  2. Oncogenes in it’s normal form the gene is called proto-oncogene. Most proto-oncogene are components of signal transduction pathways. ,translate extracellular signals into changes in gene expression by increasing the blood supply to the tumor or inhibit apoptosis.
  3. One of the the first activated oncogenes discovered by DNA Transformation process , encodes a small guanosine triphosphate binding protein 3 members of the family the H-RAS , K-RAS And N-RAS , Serves as on / off switch to activate or inhibit molecules when bound to GTP , the effect of protein effect is ended by self directed cleavage of GTP.
  4. RAS associated with plasma membrane
  5. RAS activation is done by another mechanism which is done via neclueotide substitution Note the conversion of oncogene to proto-oncogene is
  6. Proto-Oncogenes are converted to oncogenes by means of : 1-Point mutation. 2- chromosome translocation ( breakpoint can occur within 2 introns of 2 genes producing chimeric protein with novel properties ) .
  7. B lymphocytes are one of the fastest growing malignancies (B cell solid tumor ) Slid tumors are type of cancer intiated in the tissues The outer surfaces is dealt with radiotherapy whilst the vesrical is dealt with chemotherapy